Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.

[1]  W. Wilson,et al.  Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma. , 2016, Blood.

[2]  E. Campo,et al.  SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6 , 2016, Leukemia.

[3]  G. Juliusson,et al.  Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2 , 2016, Epigenetics.

[4]  J. Byrd,et al.  DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia , 2016, Nature Genetics.

[5]  A. Valencia,et al.  Non-coding recurrent mutations in chronic lymphocytic leukaemia , 2015, Nature.

[6]  Ronald P. Schuyler,et al.  Whole-genome fingerprint of the DNA methylome during human B cell differentiation , 2015, Nature Genetics.

[7]  E. Campo,et al.  Molecular evidence for antigen drive in the natural history of mantle cell lymphoma. , 2015, The American journal of pathology.

[8]  Paul Flicek,et al.  Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers , 2015, Genome research.

[9]  Michael J. Ziller,et al.  Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. , 2014, Cancer cell.

[10]  N. Friedman,et al.  Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells , 2014, Nature.

[11]  E. Giné,et al.  A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact , 2014, Leukemia.

[12]  A. Feinberg,et al.  Epigenetic stochasticity, nuclear structure and cancer: the implications for medicine , 2014, Journal of internal medicine.

[13]  Christopher R. Schmidt,et al.  Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia. , 2014, Cancer discovery.

[14]  R. Irizarry,et al.  Accounting for cellular heterogeneity is critical in epigenome-wide association studies , 2014, Genome Biology.

[15]  L. Staudt,et al.  Genome‐wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features , 2013, International journal of cancer.

[16]  J. Martín-Subero,et al.  Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer. , 2013, Biochimica et biophysica acta.

[17]  Manel Juan,et al.  Landscape of somatic mutations and clonal evolution in mantle cell lymphoma , 2013, Proceedings of the National Academy of Sciences.

[18]  A. Gnirke,et al.  Charting a dynamic DNA methylation landscape of the human genome , 2013, Nature.

[19]  D. Aran,et al.  DNA Methylation of Transcriptional Enhancers and Cancer Predisposition , 2013, Cell.

[20]  Sivan Sabato,et al.  DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes , 2013, Genome Biology.

[21]  Alfonso Valencia,et al.  Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia , 2012, Nature Genetics.

[22]  Zohar Mukamel,et al.  Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues , 2012, Nature Genetics.

[23]  E. Giné,et al.  Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. , 2012, Cancer research.

[24]  Amos Tanay,et al.  Robust 4C-seq data analysis to screen for regulatory DNA interactions , 2012, Nature Methods.

[25]  E. Campo,et al.  Molecular pathogenesis of mantle cell lymphoma. , 2012, The Journal of clinical investigation.

[26]  P. Atadja,et al.  Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells , 2012, Clinical Cancer Research.

[27]  J. Kere,et al.  Differential DNA Methylation in Purified Human Blood Cells: Implications for Cell Lineage and Studies on Disease Susceptibility , 2012, PloS one.

[28]  B. Schuster-Böckler,et al.  Chromatin organization is a major influence on regional mutation rates in human cancer cells , 2012, Nature.

[29]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[30]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[31]  B. Sander,et al.  Mantle cell lymphoma displays a homogenous methylation profile: A comparative analysis with chronic lymphocytic leukemia , 2012, American journal of hematology.

[32]  E. Giné,et al.  Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease , 2012, Leukemia.

[33]  Thomas Lengauer,et al.  BLUEPRINT to decode the epigenetic signature written in blood , 2012, Nature Biotechnology.

[34]  Ryan D. Morin,et al.  Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. , 2012, Blood.

[35]  P. Laird,et al.  Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains , 2011, Nature Genetics.

[36]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[37]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[38]  A. Rosenwald,et al.  Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. , 2011, Blood.

[39]  A. Rosenwald,et al.  Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications , 2011, PloS one.

[40]  A. Feinberg,et al.  Increased methylation variation in epigenetic domains across cancer types , 2011, Nature Genetics.

[41]  T. Mikkelsen,et al.  The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.

[42]  Amit Verma,et al.  Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. , 2010, Blood.

[43]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[44]  Nathaniel D. Heintzman,et al.  Histone modifications at human enhancers reflect global cell-type-specific gene expression , 2009, Nature.

[45]  W. D. Laat,et al.  An evaluation of 3C-based methods to capture DNA interactions , 2007, Nature Methods.

[46]  E. Campo,et al.  Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics , 2007, Nature Reviews Cancer.

[47]  J. D. Capra,et al.  A novel human B cell subpopulation representing the initial germinal center population to express AID. , 2007, Blood.

[48]  C W Caldwell,et al.  Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior , 2006, Leukemia.

[49]  I. Simon,et al.  Evidence for an instructive mechanism of de novo methylation in cancer cells , 2006, Nature Genetics.

[50]  P. Lipsky,et al.  Identification and characterization of circulating human transitional B cells. , 2005, Blood.

[51]  M. Ehrlich,et al.  The 5-methylcytosine content of DNA from human tumors. , 1983, Nucleic acids research.

[52]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.